Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asfotase Alfa in Hypophosphatasia
NCT02456038Phase 2Completed
- Sponsor
- Translational Research Center for Medical Innovation
- Start
- Aug 2014
- Primary completion
- Jul 2015
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of asfotase alfa in hypophosphatasia (HPP), sponsored by Translational Research Center for Medical Innovation. Started Aug 2014; status: completed.
02
Drugs
asfotase alfa
03
Conditions
hypophosphatasia (HPP)
Beyond the preview
Go deeper on NCT02456038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456038.